Adoptive T cell cancer therapy
Source abstract
Abstract
Tumour heterogeneity and off-target toxicity are current challenges of cancer immunotherapy. Karine Dzhandzhugazyan, Per Guldberg and Alexei Kirkin discuss how epigenetic induction of tumour antigens in antigen-presenting cells may form the basis for multi-target therapies.
The source flagged this abstract for review. Check formulas and completeness against the original publication.
Source: openaire · Quality: needs review · Source record ↗
Source flags: short_text
Source flags: short_text
Research context
OpenAlex topics: CAR-T cell therapy research · Cancer Immunotherapy and Biomarkers · Immunotherapy and Immune Responses
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (10)
Show source-provided references
1. Ribas, A. & Wolchok, J. D. Science 359, 1350–1355 (2018).10.1126/science.aar4060 ↗
2. Rizvi, N. A. et al. Science 348, 124–128 (2015).10.1126/science.aaa1348 ↗
3. Rosenberg, S. A. & Restifo, N. P. Science 348, 62–68 (2015).10.1126/science.aaa4967 ↗
4. June, C. H., O’Connor, R. S., Kawalekar, O. U., Ghassemi, S. & Milone, M. C. Science 359, 1361–1365 (2018).10.1126/science.aar6711 ↗
5. Morgan, R. A. et al. J. Immunother. 36, 133–151 (2013).10.1097/CJI.0b013e3182829903 ↗
6. McGranahan, N. et al. Science 351, 1463–1469 (2016).10.1126/science.aaf1490 ↗
7. van der Bruggen, P. et al. Science 254, 1643–1647 (1991).10.1126/science.1840703 ↗
8. Robbins, P. F. et al. J. Clin. Oncol. 29, 917–924 (2011).10.1200/JCO.2010.32.2537 ↗
9. Kirkin, A. F. et al. Nat. Commun. 9, 785 (2018).10.1038/s41467-018-03217-9 ↗
10. Krishnadas, D. K. et al. Cancer Immunol. Immunother. 64, 1251–1260 (2015).10.1007/s00262-015-1731-3 ↗